Tamar Securities LLC Acquires 1,081 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Tamar Securities LLC raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 42,602 shares of the exchange traded fund’s stock after acquiring an additional 1,081 shares during the quarter. Tamar Securities LLC owned about 0.06% of SPDR S&P Biotech ETF worth $3,837,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC boosted its position in SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC boosted its position in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after buying an additional 1,137 shares during the period. Beaton Management Co. Inc. purchased a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $212,000. Robinson Value Management Ltd. boosted its position in SPDR S&P Biotech ETF by 1.2% during the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after buying an additional 155 shares during the period. Finally, Granite Bay Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 4,965.8% during the second quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock valued at $11,097,000 after buying an additional 121,613 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.2 %

SPDR S&P Biotech ETF stock opened at $92.61 on Tuesday. The firm has a 50-day moving average of $93.35 and a 200-day moving average of $96.87. The firm has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.